News Sentiment

AXGN sentiment intelligence

Axogen Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 40.58 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-11.6% over one week, -5.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Axogen schedules investor webcast after July 29 results

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -11.6% Price reacting lower
Trend fit Trend active -5.6% over four weeks
Fair value 141.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 42
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
Stock Titan 11
TradingView 6
GlobeNewswire 4
Simply Wall Street 3
Sahm 2
Investing.com Nigeria 2
StockStory 2

Event Lens

What the news is about

Classified themes
Earnings 26
Market update 26
Analyst action 3
Balance sheet 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 57
Stock Titan Direct company coverage

Axogen schedules investor webcast after July 29 results

Axogen (Nasdaq: AXGN) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, followed by a conference call and webcast hosted by management at 8:00 a.m. ET. Investors can access the call via phone or webcast on the Axogen Investors webpag

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 10:45
Source
Stock Titan
GlobeNewswire Direct company coverage

Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026

Axogen, Inc. (Nasdaq: AXGN) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026. Following the release, Axogen management will host a conference call and webcast for the investment community at 8:00 a.m. ET. Investors can access the liv

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 07:00
Source
GlobeNewswire
Simply Wall Street Direct company coverage

Axogen (AXGN) As Russell Index Removal Tests A Narrative Of Undervaluation

Axogen (AXGN) has been removed from several Russell indexes, potentially reshaping trading patterns. Despite this, the company has shown strong long-term share price performance, though it now trades about 16% below the average analyst price target. Its fair value is estimated at

Tone
Positive 63/100
Event
Analyst action
Published
10 Jul 2026 08:09
Source
Simply Wall Street
Sahm Direct company coverage

What Axogen (AXGN)'s Russell Index Removal Means For Shareholders

Axogen, Inc. (AXGN) was removed from several Russell indexes in late June 2026, which could impact its shareholder base and trading liquidity, though it doesn't materially change near-term fundamentals. The company's investment case hinges on the post-approval ramp of its Avance

Tone
Negative 40/100
Event
Balance sheet
Published
06 Jul 2026 17:22
Source
Sahm
Simply Wall Street Direct company coverage

Axogen (AXGN) Left Russell Indices, Is The Upside Already Priced In?

Axogen (AXGN) has been removed from several Russell indices, causing a 4.7% share price decline, although it still boasts significant year-to-date and 1-year returns. Conflicting valuation narratives exist, with one model suggesting it's 13.3% undervalued at $50.78 due to strong

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 09:40
Source
Simply Wall Street
Investing.com Nigeria Direct company coverage

Axogen stock hits 52-week high at 46.05 USD By Investing.com

Axogen Inc. (AXGN) stock reached a new 52-week high of $46.05, representing a 317.97% increase over the past year and a market capitalization of $2.43 billion. This surge is supported by strong revenue growth and a high gross profit margin, reflecting positive investor confidence

Tone
Positive 80/100
Event
Earnings
Published
30 Jun 2026 20:56
Source
Investing.com Nigeria
Investing.com Direct company coverage

Axogen stock hits 52-week high at 46.05 USD

Axogen Inc. (AXGN) stock reached a new 52-week high of $46.05, representing a significant 317.97% increase over the past year and pushing its market capitalization to $2.43 billion. This surge is driven by strong revenue growth of 22% and a 75% gross profit margin. Despite its st

Tone
Positive 75/100
Event
Earnings
Published
30 Jun 2026 20:14
Source
Investing.com
marketscreener.com Direct company coverage

Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Index

Axogen, Inc. (NasdaqCM:AXGN) has been dropped from the Russell 3000E Index, the Russell Microcap Index, and the Russell 3000E Growth Benchmark. This news, published on June 29, 2026, reflects changes in the composition of these major stock market indices. The company's stock expe

Tone
Negative 29/100
Event
Market update
Published
29 Jun 2026 12:28
Source
marketscreener.com
TradingView Direct company coverage

Price to earnings forward of Axogen, Inc. – NASDAQ:AXGN

This article provides financial information for Axogen, Inc. (NASDAQ: AXGN), specifically its forward price-to-earnings ratio. It is presented in a data-driven format from TradingView, focusing on key financial metrics for investors. The content is sparse, indicating the user wou

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 09:41
Source
TradingView
Stock Titan Direct company coverage

Axogen (AXGN) director Paul Thomas receives $235K RSU grant vesting in 2027

Axogen, Inc. director Paul Thomas has been granted 5,579 restricted stock units (RSUs) valued at $235,000 as equity compensation for his Board service. These RSUs will vest on June 24, 2027, which marks the one-year anniversary of the grant date. Following this transaction, Thoma

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 07:40
Source
Stock Titan
Stock Titan Direct company coverage

Axogen (AXGN) director Alan Levine granted 4,392 RSUs valued at $185K

Axogen, Inc. director Alan M. Levine was granted 4,392 restricted stock units (RSUs) as an annual equity award for his service on the Board. The grant is valued at $185,000 and the RSUs are set to vest on June 24, 2027, which is the one-year anniversary of the grant date. Followi

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 07:40
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 4 Axogen Inc For: 26 June By Investing.com

The article "Form 4 Axogen Inc For: 26 June" from Investing.com reports on a Form 4 filing for Axogen Inc (AXGN) dated June 26, 2026. This type of filing is typically used to disclose changes in beneficial ownership of securities by company insiders. The article notes a +4.25% ch

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 21:39
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Axogen (AXGN) director receives 4,392 RSUs in $185,000 equity grant

Axogen, Inc. director Joseph A. Tyndall received an equity grant of 4,392 restricted stock units (RSUs) as compensation for his board service. This grant is valued at $185,000 and will vest on June 24, 2027, which is the one-year anniversary of the grant date. Following this awar

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

Axogen (AXGN) director receives 4,392 restricted stock units in annual equity grant

Axogen, Inc. director William P. Burke received an annual equity grant of 4,392 restricted stock units (RSUs) as compensation for his service on the Board of Directors. These RSUs, valued at $185,000 as of the grant date, represent a contingent right to receive one share of Axoge

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

Axogen (AXGN) director receives $185K equity grant of 4,392 RSUs vesting 2027

Axogen, Inc. director Kathy Johnson Weiler was granted 4,392 restricted stock units (RSUs) as part of her annual equity compensation, valued at $185,000. These RSUs represent a contingent right to receive one share of Axogen common stock per unit and are set to vest on June 24, 2

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

Axogen (AXGN) director John Johnson receives 4,392 RSUs valued at $185,000

Axogen, Inc. director John Johnson received an annual equity grant of 4,392 restricted stock units (RSUs) as compensation for his service on the Board of Directors. This award, valued at $185,000, is scheduled to vest on June 24, 2027, provided service conditions are met. Each RS

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

Axogen (AXGN) director Wendell McBride awarded 4,392 RSUs valued at $185,000

Axogen (AXGN) director Wendell Amy McBride was granted 4,392 Restricted Stock Units (RSUs) as an annual equity award for her service on the Board of Directors. The grant, valued at $185,000, represents a contingent right to receive one share of common stock per unit, vesting on J

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:41
Source
Stock Titan
GuruFocus Direct company coverage

Q1 2025 AxoGen Inc Earnings Call Transcript

This article provides the Q1 2025 earnings call transcript for AxoGen Inc (AXGN), detailing positive outcomes such as a 17.4% revenue increase and progress on a biologics license application (BLA) for advanced nerve graft. However, it also highlights negative aspects including a

Tone
Positive 71/100
Event
Earnings
Published
26 Jun 2026 12:41
Source
GuruFocus
TradingView Direct company coverage

AXGN Forecast — Price Target — Prediction for 2027

This article provides a forecast for Axogen, Inc. (AXGN) stock, including price targets and analyst ratings for 2027. It details financial information, historical price performance, and upcoming earnings dates, alongside frequently asked questions about the company's stock, marke

Tone
Positive 70/100
Event
Analyst action
Published
26 Jun 2026 08:10
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Axogen, Inc. – FWB:LT3

This article focuses on the "Price to earnings forward" metric for Axogen, Inc. (FWB:LT3). The content provided is minimal, only stating the period, value, and change for this financial metric, alongside a note that it was "Made by humans."

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 21:39
Source
TradingView
TradingView Direct company coverage

Axogen, Inc. Actuals & Estimates (NASDAQ:AXGN)

This article provides an in-depth financial overview of Axogen, Inc. (NASDAQ:AXGN), including its current stock price, historical performance, analyst forecasts, and various financial metrics. It details income statement, balance sheet, and cash flow data, alongside frequently as

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 18:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Axogen, Inc. – NASDAQ:AXGN

This article focuses on the enterprise value to revenue forward metric for Axogen, Inc. (NASDAQ: AXGN). It appears to be a financial data point provided by TradingView, indicating a key valuation ratio for the company. The content itself is an extremely sparse snippet, likely a t

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 14:39
Source
TradingView
Simply Wall Street Direct company coverage

Axogen (AXGN) Stock After 314% One-Year Surge Is The Rally Losing Steam?

Axogen (AXGN) has seen a significant 314% surge over the past year, leading investors to question if its current price of US$42.52 is sustainable. Despite this strong performance, Simply Wall St's valuation checks, including Discounted Cash Flow and Price/Sales analysis, suggest

Tone
Negative 28/100
Event
Balance sheet
Published
25 Jun 2026 14:11
Source
Simply Wall Street
TradingView Direct company coverage

Price to book forward of Axogen, Inc. – NASDAQ:AXGN

This page from TradingView provides financial information for Axogen, Inc. under the NASDAQ:AXGN ticker. It specifically highlights the "Price to book forward" metric for the company. The content also lists various features and services offered by TradingView.

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 04:09
Source
TradingView